Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dawe
    Senior Member
    • Apr 2009
    • 258

    cuffdiff and limma, puzzled by the differences

    Hi all, I've been using cuffdiff for a long time but recently I've given limma (voom) a try for RNA-seq data and compared the results.
    The experiment is quite simple, a triplicate in a treatment vs control experiment (60M read tags for each sample). Cuffdiff finds almost 300 DGE, where limma finds almost 900. Almost 100 are in common between the two.
    I have qPCR control for 3 genes and, according to the fold change, both the approaches are concordant with qPCR data. I understand that this is not an extensive test, but it is what can ben typically done within a lab (I mean, check few genes by qPCR). As a matter of facts, the FPKM quantification and the CPM quantification (cuffdiff vs limma) are quite consistent, the statistical test is making all the difference.
    I've tried some pathway analysis to see if the two approaches are similar from the ontologic point of view... well, this is not really the case (there are some overlapping pathways, of course, but all in all the experiments are saying something different)
    I see that others have tried such comparisons, with different results, now I realise I'm stuck in choosing the proper analysis approach... any hint?

    d
  • DZhang
    Senior Member
    • Jun 2010
    • 177

    #2
    Dawe,

    Depending on what's downstream experiment(s), you may focus on the overlapping 100 genes. (I assume you used the same fold/FDR criteria for both programs.) You may also plot them on a volcano plot to see where most of the overlapping occurs. If it occurs at high folder change and/or low FDR, you may tighten your filtering criteria accordingly to improve the overlap pool.

    Best regards,
    Douglas

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    212 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...